Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss treatments work better with lifestyle changes.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Lupus can cause hair loss and nail changes, with treatments available for both.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

The Seoul International Dermatology Symposium was a successful event that highlighted new dermatology treatments and fostered international relations.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

LEF1 is essential for the development of airway glands and is regulated by the Wnt/ß-catenin pathway.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Calcium reduces involucrin in rat hair bulbs but doesn't affect filaggrin and Kdap.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.